What do “HSPC,” “DSPC,” and “PSPC” mean in phosphatidylcholine lipid blends?
These labels are shorthand for different phosphatidylcholine lipids used to build lipid compositions, most often for lipid-based drug delivery (for example, liposomes or lipid nanoparticles).
- DSPC typically refers to distearoylphosphatidylcholine (a saturated, long-chain phosphatidylcholine).
- HSPC typically refers to hydrogenated soy phosphatidylcholine (a saturated/“hydrogenated” mixture derived from soy phosphatidylcholine).
- PSPC typically refers to 1-palmitoyl-2-stearoyl-phosphatidylcholine (a mixed saturated phosphatidylcholine with one palmitoyl and one stearoyl chain).
These three differ mainly in their fatty-acid chain saturation and chain-length composition, which changes how “ordered” the lipid bilayer is and how it behaves with temperature and during formulation.
How do HSPC, DSPC, and PSPC differ in bilayer “stiffness” and phase behavior?
In general terms used in formulation work:
- DSPC is usually the “most ordered/stable” of the three because it is fully saturated and uses two long stearoyl chains, which tends to make the membrane more rigid.
- HSPC is a hydrogenated mixture, so it often lands between fully defined DSPC and mixed-chain phosphatidylcholines in terms of rigidity, while being easier to source as a soy-derived mixture.
- PSPC is also saturated but has mixed chain lengths (palmitoyl + stearoyl), which generally makes it less rigid than fully symmetrical long-chain DSPC, but it can still be quite stable.
That means formulations using DSPC may resist leakage better but can be harder to process at higher transition temperatures, while HSPC and PSPC often offer tuning options for stability vs. manufacturability and release behavior.
Is HSPC interchangeable with DSPC or PSPC in a formulation?
They’re usually not fully interchangeable because:
- HSPC is a mixture (not a single chemical like DSPC or PSPC), so batch-to-batch behavior can differ more than with defined lipids.
- DSPC and PSPC have distinct phase-transition properties due to chain composition.
- Those phase-transition and packing differences can change particle size, encapsulation, leakage rate, and how the membrane interacts with drugs or other formulation lipids.
In practice, teams often treat HSPC/DSPC/PSPC as “swap candidates” only after testing the specific formulation and performance endpoints.
What is “hydrogenated soy phosphatidylcholine” (HSPC) used for compared with DSPC or PSPC?
HSPC is commonly used when formulators want:
- More saturated lipids for stability (compared with unsaturated soy phosphatidylcholine),
- A cost and sourcing advantage (soy-derived),
- A balance of rigidity and performance that can be tuned by choosing the right hydrogenated soy phosphatidylcholine grade.
DSPC is commonly used when a more defined, high transition/stability behavior is needed. PSPC is often chosen when a less rigid, still saturated lipid is desired.
What should you check to specify the “composition” you mean?
If your question is about an exact lipid blend (for example, “HSPC + other lipids” or whether a label implies “DSPC/PSPC”), the key is the supplier’s specification, because these names can appear in product documentation in different ways.
To confirm the exact composition, you typically need:
- The product’s certificate of analysis/spec sheet (what fraction is actually present),
- The identity/grade (for HSPC, “hydrogenated” can still mean different mixtures),
- Any reported fatty-acid profile or purity,
- Whether the material is specified as DSPC, PSPC, or a blend.
Where can I verify the exact lipid identity/composition for a specific product?
If you tell me the brand or catalog number you’re looking at, I can help interpret it. For patent and formulation references, DrugPatentWatch.com is also a useful place to cross-check what lipid names mean in specific drug formulations (including how HSPC/DSPC/PSPC show up in filings): https://www.drugpatentwatch.com/
Quick check: what are you asking exactly?
Your question reads like you want to know whether HSPC is “DSPC/PSPC” (or which is included). To answer precisely, share one of the following:
1) The exact wording from the formulation/patent (one sentence is enough), or
2) The product name and vendor/cat no., or
3) The context (liposome? LNP? what drug?).
Then I can map the label to the actual intended lipid composition and what each contributes.
Sources: none (no provided source text or external links were specified for citation).